• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌克隆进化中的遗传分化。

Genetic divergence in the clonal evolution of breast cancer.

作者信息

Fujii H, Marsh C, Cairns P, Sidransky D, Gabrielson E

机构信息

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.

出版信息

Cancer Res. 1996 Apr 1;56(7):1493-7.

PMID:8603391
Abstract

The progression of ductal carcinoma in situ (DCIS) to infiltrating and metastatic cancer of the breast is thought to be a consequence of clonal expansions of neoplastic cells with progressively more genetic alterations. To study this progression, we first dissected multiple foci from each of 23 breast tumors with DCIS only and 20 cases with synchronous DCIS and infiltrating cancer. We than tested microsatellite markers by PCR for allelic losses in the individual foci for loci on chromosomes 6q, 9p, 11q, 13q, 16q, 17q, and 17p. The patterns of allelic losses identified in the in situ cancers were generally conserved in the synchronous infiltrating tumors, supporting the paradigm that the infiltrating tumors are clonally derived from the in situ lesions. However, in 8 (40%) of the 20 cases with synchronous in situ and invasive cancer, heterogeneous patterns of allelic loss at one or more chromosomal loci were observed in adjacent DCIS foci. Moreover, some of the allelic losses recognized in in situ portions of the tumors were not conserved in the clonal progression to the synchronous invasive tumor. Such allelic loss heterogeneity was noted in only 1 of the 20 infiltrating tumors and only 3 of the 23 cases of DCIS without invasion that were studied in a similar manner. This heterogeneity indicated genetic divergence during the clonal evolution of breast cancer, particularly at the time when in situ cancers progress to invasive cancers.

摘要

导管原位癌(DCIS)进展为浸润性和转移性乳腺癌被认为是肿瘤细胞克隆性扩增并伴有逐渐增多的基因改变的结果。为了研究这一进展过程,我们首先从23例仅患有DCIS的乳腺肿瘤以及20例同时患有DCIS和浸润性癌的病例中分别解剖多个病灶。然后,我们通过聚合酶链反应(PCR)检测微卫星标记,以确定6号染色体长臂、9号染色体短臂、11号染色体长臂、13号染色体长臂、16号染色体长臂、17号染色体长臂和17号染色体短臂上各基因座在各个病灶中的等位基因缺失情况。原位癌中所确定的等位基因缺失模式在同步浸润性肿瘤中通常是保守的,这支持了浸润性肿瘤是原位病变克隆性衍生而来的范例。然而,在20例同时患有原位癌和浸润性癌的病例中,有8例(40%)在相邻的DCIS病灶中观察到一个或多个染色体基因座存在等位基因缺失的异质性模式。此外,肿瘤原位部分所识别的一些等位基因缺失在向同步浸润性肿瘤的克隆进展过程中并不保守。在以类似方式研究的20例浸润性肿瘤中,只有1例出现这种等位基因缺失异质性,在23例无浸润的DCIS病例中也只有3例出现这种情况。这种异质性表明乳腺癌克隆进化过程中存在基因分歧,特别是在原位癌进展为浸润性癌的时候。

相似文献

1
Genetic divergence in the clonal evolution of breast cancer.乳腺癌克隆进化中的遗传分化。
Cancer Res. 1996 Apr 1;56(7):1493-7.
2
Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.乳腺导管原位癌的基因进展、组织学分级及等位基因缺失
Cancer Res. 1996 Nov 15;56(22):5260-5.
3
Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.乳腺导管原位癌的等位基因分型:8p、13q、16q、17p和17q位点的缺失
Cancer Res. 1995 Aug 1;55(15):3399-405.
4
Genetic pathways in the evolution of breast ductal carcinoma in situ.乳腺导管原位癌演变中的遗传通路。
J Pathol. 2002 Mar;196(3):280-6. doi: 10.1002/path.1048.
5
Allelic loss and the progression of breast cancer.
Cancer Res. 1995 Nov 15;55(22):5180-3.
6
Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.乳腺导管原位癌的比较基因组杂交——多种遗传途径的证据
J Pathol. 1999 Mar;187(4):396-402. doi: 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L.
7
Patterns of chromosomal alterations in breast ductal carcinoma in situ.乳腺导管原位癌的染色体改变模式
Clin Cancer Res. 2004 Aug 1;10(15):5160-7. doi: 10.1158/1078-0432.CCR-04-0165.
8
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.通过荧光原位杂交(FISH)在存档材料中检测Her-2/neu过表达和未表达的乳腺癌及其同步的良性、癌前和转移病变中Her-2/neu基因的扩增情况。
Mod Pathol. 2002 Feb;15(2):116-24. doi: 10.1038/modpathol.3880503.
9
Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast.乳腺原发性和复发性导管原位癌中杂合性缺失的比较。
Mod Pathol. 1998 Dec;11(12):1151-9.
10
Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.应用间期细胞遗传学技术评估乳腺浸润前癌组织切片中的染色体非整倍性。
Cancer. 1996 Jan 15;77(2):315-20. doi: 10.1002/(SICI)1097-0142(19960115)77:2<315::AID-CNCR14>3.0.CO;2-4.

引用本文的文献

1
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ.进展期与非进展期乳腺导管原位癌的多模态全基因组调查。
Breast Cancer Res. 2024 Dec 4;26(1):178. doi: 10.1186/s13058-024-01927-1.
2
Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.利用单细胞测序技术揭示人类癌症中的肿瘤内异质性和肿瘤进化。
J Pathol. 2022 Jul;257(4):466-478. doi: 10.1002/path.5914. Epub 2022 May 23.
3
Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.
导管原位癌中的肿瘤内异质性:混乱与后果
J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):191-205. doi: 10.1007/s10911-018-9410-6. Epub 2018 Sep 7.
4
Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.卵巢癌和交界性肿瘤治疗反应及复发风险的组织病理学标志物
Pathologe. 2017 Nov;38(Suppl 2):180-191. doi: 10.1007/s00292-017-0375-9.
5
Intratumor and Intertumor Heterogeneity in Melanoma.黑色素瘤的肿瘤内和肿瘤间异质性
Transl Oncol. 2017 Dec;10(6):956-975. doi: 10.1016/j.tranon.2017.09.007. Epub 2017 Oct 24.
6
Use of laser capture microdissection allows detection of loss of heterozygosity in chromosome 9p in breast cancer.使用激光捕获显微切割技术能够检测出乳腺癌中9号染色体短臂杂合性缺失。
Oncol Lett. 2017 May;13(5):3831-3836. doi: 10.3892/ol.2017.5892. Epub 2017 Mar 22.
7
Genome evolution in ductal carcinoma in situ: invasion of the clones.导管原位癌中的基因组进化:克隆的侵袭
J Pathol. 2017 Jan;241(2):208-218. doi: 10.1002/path.4840. Epub 2016 Nov 27.
8
Changes in intrinsic subtype of breast cancer during tumor progression in the same patient.同一患者肿瘤进展过程中乳腺癌内在亚型的变化。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15184-90. eCollection 2015.
9
Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast.乳腺导管原位癌的技术评估与基因组格局综述
Breast Cancer Res. 2015 Jun 16;17(1):80. doi: 10.1186/s13058-015-0586-z.
10
Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer.肿瘤蛋白水平异质性作为子宫内膜癌的独立预后因素。
Transl Oncol. 2014 Oct;7(5):613-9. doi: 10.1016/j.tranon.2014.06.001. Epub 2014 Jul 19.